CASI Crosses Above Average Analyst Target
April 04, 2018 at 09:33 AM EDT
In recent trading, shares of CASI Pharmaceuticals, Inc. (CASI) have crossed above the average analyst 12-month target price of $5.83, changing hands for $6.30/share..